RECRUITING

New MRI Biomarkers in Head and Neck Cancers

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Magnetic resonance imaging (MRI) is a diagnostic technique that takes pictures of organs of the body. It uses magnetic fields and radio waves that cannot be felt. This makes specific organs, blood vessels, or tumors easier to see. Diffusion MRI lets us measure the motion of water in the tumor. The purpose of this study is to see if new MRI methods can give us more information about the tumor.

Official Title

Quantitative Imaging Tools to Derive DW-MRI Oncological Biomarkers

Quick Facts

Study Start:2018-03-16
Study Completion:2025-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03483337

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age ≥ 18 years
  2. * Group 1 patients: Presence of a suspicious metastatic lesion or suspicious for recurrent disease in the head and neck region.
  3. * Group 2 patients:
  4. * Biopsy proven recurrent or metastatic or definitive head and neck cancer or (differentiated and undifferentiated) thyroid cancers in the head and neck region only.
  5. * Patients planning to undergo reatment at MSK
  1. * Patient would require anesthesia for the study
  2. * Patients who are claustrophobic
  3. * Patients selecting treatment outside of MSK
  4. * Known reaction to Gd based contrast agent
  5. * Patients who have presence of a known contradiction to MRI
  6. * Pacemaker
  7. * Aneurysm clips
  8. * Patients with implants that are contradicted for MR imaging will be excluded
  9. * Pregnant
  10. * Age and mental status wherein he /she is unable to cooperate for MRI study

Contacts and Locations

Study Contact

Amita Dave, PhD
CONTACT
212-639-3184
davea@mskcc.org
Alan Ho, MD, PhD
CONTACT
646-608-3774

Principal Investigator

Amita Dave, PhD
PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center

Study Locations (Sites)

Memorial Sloan Kettering Cancer Center
New York, New York, 10065
United States

Collaborators and Investigators

Sponsor: Memorial Sloan Kettering Cancer Center

  • Amita Dave, PhD, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-03-16
Study Completion Date2025-03

Study Record Updates

Study Start Date2018-03-16
Study Completion Date2025-03

Terms related to this study

Keywords Provided by Researchers

  • (DW)-MRI
  • oncological biomarkers
  • metastatic
  • recurrent
  • 18-063

Additional Relevant MeSH Terms

  • Head and Neck Cancer
  • Thyroid Cancer